Highly pathogenic avian influenza confirmed on Bird Island, South Georgia – the first known cases in Antarctic
On Oct. 23, 2023, the British Antarctic Survey (BAS) reported that Highly Pathogenic Avian Influenza (HPAI) had been…
On Oct. 23, 2023, the British Antarctic Survey (BAS) reported that Highly Pathogenic Avian Influenza (HPAI) had been…
On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…
On Oct. 17, 2023, the U.S. Department of Agriculture’s (USDA) announced a new partnership between the National Bio…
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
On Oct. 12, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that two fatal human…
On Oct. 11, 2023, the European Commission, the European Investment Bank and the Bill & Melinda Gates Foundation…
On Oct. 10, 2023, the University of Wisconsin-Madison researchers announced a new study published in the journal Neuron…
On Oct. 7, 2023, California became the first state to ban four chemicals used in well-known candies and…
On Oct. 3, 2023, Vir Biotechnology announced that the Biomedical Advanced Research and Development Authority (BARDA), part of…
On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…
On Oct. 2, 2023, the California Institute for Regenerative Medicine (CIRM) announced its approval of a new program…
On Sept. 29, 2023, through the Future Manufacturing program, the U.S. National Science Foundation (NSF) announced targeted investments…
On Sept. 29, 2023, the U.S. Food and Drug Administration (FDA) granted Invitae de novo marketing authorization for…
On Sept. 29, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $43.8 million to fund projects aimed…
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
On Sept. 28, 2023, the U.S. Department of Agriculture’s (USDA)Â Animal and Plant Health Inspection Service (APHIS) announced…
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
On Sept. 26, 2023, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced…
On Sept. 20, 2023, the National Institutes of Health announced that a trial of a preventive HIV vaccine…
On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…
On Sept. 14, 2023, the World Health Organization (WHO) reported that as of Sept. 11, 2023, a total…
On Sept. 14, 2023, Northwestern University announced it had been awarded $50 million over five years from the…
On Sept. 12, 2023, the National Institutes of Health announced it was establishing the Multi-Omics for Health and…
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…